Accounts Receivable

3 Months Ended

Mar. 31, 2024

3. Accounts Receivable

Accounts receivable, net consists of the following (in thousands):


	March 31, 2024			December 31, 2023
Accounts receivable – commercial
Accounts receivable, gross	$	17,516		$	20,199
Wholesaler distribution fees and prompt pay discounts		(2,252	)		(2,469	)
Reserve for returns		(5,597	)		(6,215	)
Allowance for credit losses		(157	)		(157	)
Total accounts receivable – commercial, net		9,510			11,358
Accounts receivable – collaborations and services		10,402			3,543
Total accounts receivable, net	$	19,912		$	14,901

As of March 31, 2024 and December 31, 2023, the allowance for credit losses and doubtful accounts for commercial accounts receivable of $0.2 million was related to $0.2 million of accounts receivable for Zealand Pharma US, Inc. As of March 31, 2024, the Company had three wholesale distributors representing approximately 78% of commercial accounts receivable and 70% of gross sales during the three months ended March 31, 2024.

As of March 31, 2024 and December 31, 2023, there was no allowance for credit losses for accounts receivable for collaborations and services. The Company had one collaboration partner, UT, that comprised 100% of the collaboration and services net accounts receivable as of March 31, 2024 and December 31, 2023 and approximately 100% of gross revenue from collaborations and services for the three months ended March 31, 2024 and 2023.